LYNN L SEVERSON NP
Prescription History 1497987796
Nurse Practitioner in Eau Claire, WI

NPI Status: Active since August 20, 2009

Contact Information

733 W CLAIREMONT AVE
EAU CLAIRE, WI
ZIP 54701
Phone: (715) 838-5222

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for LYNN L SEVERSON NP, an active Nurse Practitioner specialist practicing in Eau Claire, WI. Our medical registry currently tracks 30 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 1,241 documented patient claims. Among these therapy options, the most frequently utilized medication is Novolog Flexpen, which accounts for 160 claims alone.


Baqsimi

Generic Formulation: GlucagonSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 15
30-Day Fills 15.7
Days Supply 250
WI State Average Benchmarks
Peer Average Claims14.0
Peer Average 30-Day Fills15.1
Peer Average Days Supply128
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across WI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $4,794.67 across this reporting matrix range.

Provider Avg Cost Per Claim

$319.64

State Avg Cost Per Claim

$520.40

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

Peptides derived from proglucagon which is also the precursor of pancreatic GLUCAGON. Despite expression of proglucagon in multiple tissues, the major production site of glucagon-like peptides (GLPs) is the INTESTINAL L CELLS. GLPs include glucagon-like peptide 1, glucagon-like peptide 2, and the various truncated forms.

Therapeutic Applications

This medication is the same as your body's own glucagon, a natural substance that raises blood sugar by causing the body to release sugar stored in the liver. It is used to treat very low blood sugar (hypoglycemia) that may cause you to need help from others. Make sure a family member or caregiver knows where you keep this medication and how to use it before you need their help.

Droplet Pen Needle

Generic Formulation: Pen Needle, DiabeticSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 13
30-Day Fills 39.0
Days Supply 1,170
WI State Average Benchmarks
Peer Average Claims16.0
Peer Average 30-Day Fills43.6
Peer Average Days Supply1,303
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across WI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,175.71 across this reporting matrix range.

Provider Avg Cost Per Claim

$90.44

State Avg Cost Per Claim

$85.94

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Glimepiride

Generic Formulation: GlimepirideSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 11
30-Day Fills 33.0
Days Supply 990
WI State Average Benchmarks
Peer Average Claims38.0
Peer Average 30-Day Fills97.4
Peer Average Days Supply2,899
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 71.1% less volume than the regional standard for practitioners inside WI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $353.95 across this reporting matrix range.

Provider Avg Cost Per Claim

$32.18

State Avg Cost Per Claim

$12.00

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

Alkaloids derived from TYRAMINE combined with 3,4-dihydroxybenzaldehyde via a norbelladine pathway, including GALANTAMINE, lycorine and crinine. They are found in the AMARYLLIDACEAE plant family.

Therapeutic Applications

Glimepiride is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. It may also be used with other diabetes medications. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Glimepiride belongs to the class of drugs known as sulfonylureas. It lowers blood sugar by causing the release of your body's natural insulin.

Glipizide

Generic Formulation: GlipizideSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 31
30-Day Fills 71.0
Days Supply 2,118
WI State Average Benchmarks
Peer Average Claims33.0
Peer Average 30-Day Fills79.0
Peer Average Days Supply2,345
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across WI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $499.79 across this reporting matrix range.

Provider Avg Cost Per Claim

$16.12

State Avg Cost Per Claim

$9.74

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An oral hypoglycemic agent which is rapidly absorbed and completely metabolized.

Therapeutic Applications

Glipizide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. It may also be used with other diabetes medications. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Glipizide belongs to the class of drugs known as sulfonylureas. It lowers blood sugar by causing the release of your body's natural insulin.

Glipizide Er

Generic Formulation: GlipizideSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 16
30-Day Fills 24.0
Days Supply 685
WI State Average Benchmarks
Peer Average Claims33.0
Peer Average 30-Day Fills83.3
Peer Average Days Supply2,480
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 51.5% less volume than the regional standard for practitioners inside WI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $294.76 across this reporting matrix range.

Provider Avg Cost Per Claim

$18.42

State Avg Cost Per Claim

$21.42

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An oral hypoglycemic agent which is rapidly absorbed and completely metabolized.

Therapeutic Applications

Glipizide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. It may also be used with other diabetes medications. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Glipizide belongs to the class of drugs known as sulfonylureas. It lowers blood sugar by causing the release of your body's natural insulin.

Humalog

Generic Formulation: Insulin LisproSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 18
30-Day Fills 24.9
Days Supply 706
WI State Average Benchmarks
Peer Average Claims21.0
Peer Average 30-Day Fills35.9
Peer Average Days Supply987
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across WI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $12,542.70 across this reporting matrix range.

Provider Avg Cost Per Claim

$696.82

State Avg Cost Per Claim

$993.85

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

Insulin that has been modified so that the B-chain contains a LYSINE at position 28 instead of a PROLINE and a PROLINE at position 29 instead of a LYSINE. It is used to manage BLOOD GLUCOSE levels in patients with TYPE 2 DIABETES.

Therapeutic Applications

Insulin lispro is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin lispro is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin lispro starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin lispro may also be used with other oral diabetes medications (such as sulfonylureas like glyburide or glipizide).

Humalog Kwikpen U-100

Generic Formulation: Insulin LisproSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 70
30-Day Fills 139.5
Days Supply 4,160
WI State Average Benchmarks
Peer Average Claims27.0
Peer Average 30-Day Fills51.6
Peer Average Days Supply1,461
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 159.3% higher than the standard regional baseline profile for WI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $95,401.16 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,362.87

State Avg Cost Per Claim

$1,169.30

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

Insulin that has been modified so that the B-chain contains a LYSINE at position 28 instead of a PROLINE and a PROLINE at position 29 instead of a LYSINE. It is used to manage BLOOD GLUCOSE levels in patients with TYPE 2 DIABETES.

Therapeutic Applications

Insulin lispro is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin lispro is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin lispro starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin lispro may also be used with other oral diabetes medications (such as sulfonylureas like glyburide or glipizide).

Humalog Mix 75-25 Kwikpen

Generic Formulation: Insulin Lispro Protamin/LisproSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 54
30-Day Fills 83.1
Days Supply 2,474
WI State Average Benchmarks
Peer Average Claims19.0
Peer Average 30-Day Fills29.5
Peer Average Days Supply813
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 184.2% higher than the standard regional baseline profile for WI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $107,956.18 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,999.19

State Avg Cost Per Claim

$1,356.61

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Insulin lispro protamine/insulin lispro is used along with a proper diet and exercise program to control high blood sugar in people with diabetes. This product is a combination of two man-made insulins: intermediate-acting insulin lispro protamine and rapid-acting insulin lispro. This combination starts working faster and lasts for a longer time than regular insulin. Insulin is a natural substance that allows the body to properly use sugar from the diet. It replaces the insulin that your body no longer produces, thereby lowering your blood sugar. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke.

Insulin Syringe

Generic Formulation: Syringe And Needle,insulin,1mlSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 12
30-Day Fills 26.7
Days Supply 800
WI State Average Benchmarks
Peer Average Claims14.0
Peer Average 30-Day Fills25.2
Peer Average Days Supply711
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across WI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $956.88 across this reporting matrix range.

Provider Avg Cost Per Claim

$79.74

State Avg Cost Per Claim

$49.99

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Jardiance

Generic Formulation: EmpagliflozinSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 37
30-Day Fills 87.0
Days Supply 2,596
WI State Average Benchmarks
Peer Average Claims37.0
Peer Average 30-Day Fills68.9
Peer Average Days Supply2,026
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across WI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $54,403.10 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,470.35

State Avg Cost Per Claim

$1,069.94

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Empagliflozin is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Empagliflozin is also used in patients with type 2 diabetes and heart disease to lower the risk of death from heart attack or stroke. Empagliflozin works by increasing the removal of sugar by your kidneys. Empagliflozin is also used to treat heart failure. It may help you live longer and lower your risk of going to the hospital for heart failure. Empagliflozin works by increasing the removal of sodium by your kidneys.

Lantus

Generic Formulation: Insulin Glargine,hum.Rec.AnlogSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 18
30-Day Fills 33.8
Days Supply 1,005
WI State Average Benchmarks
Peer Average Claims22.0
Peer Average 30-Day Fills31.3
Peer Average Days Supply847
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across WI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $31,020.28 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,723.35

State Avg Cost Per Claim

$624.13

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A recombinant LONG ACTING INSULIN and HYPOGLYCEMIC AGENT that is used to manage BLOOD GLUCOSE in patients with DIABETES MELLITUS.

Therapeutic Applications

Insulin glargine is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin glargine is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin glargine may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. This monograph is about the following insulin glargine products: insulin glargine, insulin glargine-yfgn.

Lantus Solostar

Generic Formulation: Insulin Glargine,hum.Rec.AnlogSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 114
30-Day Fills 296.4
Days Supply 8,863
WI State Average Benchmarks
Peer Average Claims42.0
Peer Average 30-Day Fills81.0
Peer Average Days Supply2,334
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 171.4% higher than the standard regional baseline profile for WI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $90,866.67 across this reporting matrix range.

Provider Avg Cost Per Claim

$797.08

State Avg Cost Per Claim

$680.12

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A recombinant LONG ACTING INSULIN and HYPOGLYCEMIC AGENT that is used to manage BLOOD GLUCOSE in patients with DIABETES MELLITUS.

Therapeutic Applications

Insulin glargine is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin glargine is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin glargine may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. This monograph is about the following insulin glargine products: insulin glargine, insulin glargine-yfgn.

Levemir Flexpen

Generic Formulation: Insulin DetemirSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 28
30-Day Fills 65.3
Days Supply 1,931
WI State Average Benchmarks
Peer Average Claims--
Peer Average 30-Day Fills--
Peer Average Days Supply--

Provider Avg Cost Per Claim

$1,180.97

State Avg Cost Per Claim

--

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A recombinant long-acting insulin and hypoglycemic agent in which a MYRISTIC ACID is conjugated to a LYSINE at position B29. It is used to manage BLOOD GLUCOSE levels in patients with DIABETES MELLITUS.

Therapeutic Applications

Insulin detemir is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin detemir is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin detemir may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs (such as metformin, exenatide).

Levothyroxine Sodium

Generic Formulation: Levothyroxine SodiumSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 111
30-Day Fills 247.5
Days Supply 7,358
WI State Average Benchmarks
Peer Average Claims143.0
Peer Average 30-Day Fills332.2
Peer Average Days Supply9,789
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across WI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,961.52 across this reporting matrix range.

Provider Avg Cost Per Claim

$17.67

State Avg Cost Per Claim

$17.99

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.

Therapeutic Applications

Levothyroxine is used to treat an underactive thyroid (hypothyroidism). It replaces or provides more thyroid hormone, which is normally produced by the thyroid gland. Low thyroid hormone levels can occur naturally or when the thyroid gland is injured by radiation/medications or removed by surgery. Having enough thyroid hormone is important for maintaining normal mental and physical activity. In children, having enough thyroid hormone is important for normal mental and physical development. This medication is also used to treat other types of thyroid disorders (such as thyroid cancer). This medication should not be used to treat infertility unless it is caused by low thyroid hormone levels.

Metformin Hcl

Generic Formulation: Metformin HclSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 87
30-Day Fills 256.0
Days Supply 7,680
WI State Average Benchmarks
Peer Average Claims80.0
Peer Average 30-Day Fills196.8
Peer Average Days Supply5,848
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across WI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $6,250.85 across this reporting matrix range.

Provider Avg Cost Per Claim

$71.85

State Avg Cost Per Claim

$9.05

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)

Therapeutic Applications

Metformin is used with a proper diet and exercise program and possibly with other medications to control high blood sugar. It is used in patients with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Metformin works by helping to restore your body's proper response to the insulin you naturally produce. It also decreases the amount of sugar that your liver makes and that your stomach/intestines absorb.

Metformin Hcl Er

Generic Formulation: Metformin HclSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 61
30-Day Fills 151.0
Days Supply 4,488
WI State Average Benchmarks
Peer Average Claims63.0
Peer Average 30-Day Fills156.6
Peer Average Days Supply4,662
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across WI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,171.77 across this reporting matrix range.

Provider Avg Cost Per Claim

$19.21

State Avg Cost Per Claim

$11.95

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)

Therapeutic Applications

Metformin is used with a proper diet and exercise program and possibly with other medications to control high blood sugar. It is used in patients with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Metformin works by helping to restore your body's proper response to the insulin you naturally produce. It also decreases the amount of sugar that your liver makes and that your stomach/intestines absorb.

Nano 2nd Gen Pen Needle

Generic Formulation: Pen Needle, DiabeticSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 17
30-Day Fills 25.0
Days Supply 735
WI State Average Benchmarks
Peer Average Claims24.0
Peer Average 30-Day Fills58.0
Peer Average Days Supply1,723
Conservative Utilization

This provider writes prescriptions for this formulation 29.2% less frequently than the standard regional baseline metric for practitioners inside WI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,711.37 across this reporting matrix range.

Provider Avg Cost Per Claim

$100.67

State Avg Cost Per Claim

$101.58

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Novolin 70-30

Generic Formulation: Insulin Nph Hum/Reg Insulin HmSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 26
30-Day Fills 31.2
Days Supply 846
WI State Average Benchmarks
Peer Average Claims16.0
Peer Average 30-Day Fills22.6
Peer Average Days Supply617
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 62.5% higher than the standard regional baseline profile for WI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $14,037.70 across this reporting matrix range.

Provider Avg Cost Per Claim

$539.91

State Avg Cost Per Claim

$407.18

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Novolog Flexpen

Generic Formulation: Insulin AspartSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 160
30-Day Fills 285.2
Days Supply 8,413
WI State Average Benchmarks
Peer Average Claims30.0
Peer Average 30-Day Fills50.1
Peer Average Days Supply1,394
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 433.3% higher than the standard regional baseline profile for WI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $312,338.11 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,952.11

State Avg Cost Per Claim

$1,009.82

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

Insulin that has been modified to contain an ASPARTIC ACID instead of a PROLINE at position 38 of the B-chain.

Therapeutic Applications

Insulin aspart is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin aspart is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin aspart starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product.

Novolog Mix 70-30 Flexpen

Generic Formulation: Insulin Aspart Prot/Insuln AspSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 44
30-Day Fills 80.4
Days Supply 2,051
WI State Average Benchmarks
Peer Average Claims17.0
Peer Average 30-Day Fills26.8
Peer Average Days Supply727
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 158.8% higher than the standard regional baseline profile for WI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $51,578.53 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,172.24

State Avg Cost Per Claim

$1,332.74

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Insulin aspart protamine/insulin aspart is used along with a proper diet and exercise program to control high blood sugar in people with diabetes. This product is a combination of two man-made insulins: intermediate-acting insulin aspart protamine and rapid-acting insulin aspart. This combination starts working faster and lasts for a longer time than regular insulin. Insulin is a natural substance that allows the body to properly use sugar from the diet. It replaces the insulin that your body no longer produces, thereby lowering your blood sugar. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke.

Ozempic

Generic Formulation: SemaglutideSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 43
30-Day Fills 53.8
Days Supply 1,540
WI State Average Benchmarks
Peer Average Claims36.0
Peer Average 30-Day Fills53.2
Peer Average Days Supply1,545
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across WI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $54,382.32 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,264.71

State Avg Cost Per Claim

$1,353.85

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Semaglutide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Semaglutide is also used in people with type 2 diabetes and heart disease to lower the risk of death from heart attack or stroke. Semaglutide is similar to a natural hormone in your body (incretin). It works by causing insulin release in response to high blood sugar (such as after a meal) and decreasing the amount of sugar your liver makes. If you use insulin, semaglutide is not a substitute for insulin treatment.

Semglee (Yfgn) Pen

Generic Formulation: Insulin Glargine-YfgnSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 24
30-Day Fills 56.1
Days Supply 1,681
WI State Average Benchmarks
Peer Average Claims13.0
Peer Average 30-Day Fills14.5
Peer Average Days Supply320
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 84.6% higher than the standard regional baseline profile for WI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $13,997.25 across this reporting matrix range.

Provider Avg Cost Per Claim

$583.22

State Avg Cost Per Claim

$269.03

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Insulin glargine is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin glargine is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin glargine may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. This monograph is about the following insulin glargine products: insulin glargine, insulin glargine-yfgn.

Tresiba Flextouch U-100

Generic Formulation: Insulin DegludecSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 27
30-Day Fills 57.9
Days Supply 1,735
WI State Average Benchmarks
Peer Average Claims25.0
Peer Average 30-Day Fills50.5
Peer Average Days Supply1,468
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across WI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $23,744.97 across this reporting matrix range.

Provider Avg Cost Per Claim

$879.44

State Avg Cost Per Claim

$730.67

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Insulin degludec is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin degludec is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin degludec may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs.

Tresiba Flextouch U-200

Generic Formulation: Insulin DegludecSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 11
30-Day Fills 19.0
Days Supply 568
WI State Average Benchmarks
Peer Average Claims26.0
Peer Average 30-Day Fills47.7
Peer Average Days Supply1,370
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 57.7% less volume than the regional standard for practitioners inside WI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $15,171.13 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,379.19

State Avg Cost Per Claim

$1,426.16

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Insulin degludec is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin degludec is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin degludec may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs.

Trulicity

Generic Formulation: DulaglutideSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 57
30-Day Fills 67.8
Days Supply 1,932
WI State Average Benchmarks
Peer Average Claims42.0
Peer Average 30-Day Fills60.1
Peer Average Days Supply1,728
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 35.7% more claims than the standard regional baseline profile for WI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $68,889.63 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,208.59

State Avg Cost Per Claim

$1,345.29

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Dulaglutide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. This medication is also used to lessen the risk of a major cardiovascular event (such as heart attack or stroke) in people who already have, or are at high risk for heart/blood vessel disease. Dulaglutide is similar to a natural hormone in your body (incretin). It works by causing insulin release in response to high blood sugar (such as after a meal) and by decreasing the amount of sugar your liver makes. Dulaglutide is not a substitute for insulin if you need insulin treatment.

Ultra-Fine Mini Pen Needle

Generic Formulation: Pen Needle, DiabeticSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 45
30-Day Fills 87.6
Days Supply 2,590
WI State Average Benchmarks
Peer Average Claims22.0
Peer Average 30-Day Fills49.1
Peer Average Days Supply1,451
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 104.5% higher than the standard regional baseline profile for WI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $4,918.99 across this reporting matrix range.

Provider Avg Cost Per Claim

$109.31

State Avg Cost Per Claim

$96.04

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Ultra-Fine Nano Pen Needle

Generic Formulation: Pen Needle, DiabeticSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 29
30-Day Fills 39.9
Days Supply 1,196
WI State Average Benchmarks
Peer Average Claims21.0
Peer Average 30-Day Fills47.1
Peer Average Days Supply1,386
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 38.1% more claims than the standard regional baseline profile for WI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,380.47 across this reporting matrix range.

Provider Avg Cost Per Claim

$82.09

State Avg Cost Per Claim

$89.07

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Ultra-Fine Short Pen Needle

Generic Formulation: Pen Needle, DiabeticSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 27
30-Day Fills 68.8
Days Supply 2,060
WI State Average Benchmarks
Peer Average Claims19.0
Peer Average 30-Day Fills44.4
Peer Average Days Supply1,310
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 42.1% more claims than the standard regional baseline profile for WI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $4,798.70 across this reporting matrix range.

Provider Avg Cost Per Claim

$177.73

State Avg Cost Per Claim

$96.96

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Unifine Pentips

Generic Formulation: Pen Needle, DiabeticSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 11
30-Day Fills 24.3
Days Supply 725
WI State Average Benchmarks
Peer Average Claims17.0
Peer Average 30-Day Fills28.8
Peer Average Days Supply817
Conservative Utilization

This provider writes prescriptions for this formulation 35.3% less frequently than the standard regional baseline metric for practitioners inside WI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $833.14 across this reporting matrix range.

Provider Avg Cost Per Claim

$75.74

State Avg Cost Per Claim

$42.78

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Victoza 3-Pak

Generic Formulation: LiraglutideSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 24
30-Day Fills 36.0
Days Supply 1,080
WI State Average Benchmarks
Peer Average Claims20.0
Peer Average 30-Day Fills30.3
Peer Average Days Supply903
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across WI. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $39,912.14 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,663.01

State Avg Cost Per Claim

$1,565.21

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An analog of GLUCAGON-LIKE PEPTIDE 1 and agonist of the GLUCAGON-LIKE PEPTIDE 1 RECEPTOR that is used as a HYPOGLYCEMIC AGENT and supplemental therapy in the treatment of DIABETES MELLITUS by patients who do not respond to METFORMIN.

Therapeutic Applications

This medication is used with a doctor-approved exercise, behavior change, and reduced-calorie diet program to help you lose weight. It is used by certain overweight people, such as those who are obese or have weight-related medical problems. Losing weight and keeping it off can lessen the many health risks that come with obesity, including heart disease, diabetes, high blood pressure, and a shorter life. Liraglutide is similar to a natural hormone in your body (incretin). It works by controlling your appetite.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like LYNN L SEVERSON NP provides transparency into local medical care patterns within Eau Claire, WI.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Nurse Practitioner** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.